Browsing: Human Genome News
US biopharmaceutical firm Human Genome Sciences (NASDAQ:HGSI), or HGS, reiterated its advice to shareholders not to tender their stock to the $13.00 (EUR10.30) a share hostile…
Amadeus House 27b Floral Street London WC2E 9DP United Kingdom
editor@financial-news.co.uk.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Copyright © 2026 Financial News